Skip to content

Davis Matthew W.

Reporting owner on Forms 3, 4 and 5, CIK 2094283.

Davis Matthew W. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
AQST · Aquestive Therapeutics, Inc.CIK 1398733officer (Chief Development Officer)22026-11-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
AQST · Aquestive Therapeutics, Inc.Common Stock2026-11-12S sold-7,197$3.546887,500Form 4
AQST · Aquestive Therapeutics, Inc.Common Stock2026-11-10F withheld for tax-5,303$3.5294,697Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001214659-26-014337 Aquestive Therapeutics, Inc.2026-11-16
Form 4 0001214659-26-014000 Aquestive Therapeutics, Inc.2026-11-12